Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
| ▸ | CTSB | P07858 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13915583 | 0.93 | ADRB3 (0.59) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL13915582 | 0.93 | ADRB3 (0.58) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL13509411 | 0.90 | ADRB3 (0.67) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL13509424 | 0.90 | ADRB3 (0.60) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL13915581 | 0.89 | ADRB3 (0.55) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL13509439 | 0.89 | ADRB3 (0.59) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL13915585 | 0.88 | ADRB3 (0.52) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL14031195 | 0.88 | ADRB3 (0.52) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL13509467 | 0.88 | ADRB3 (0.56) | ADRB3ADRA2BADRA2CCTSBCYP3A4 | |
| SCHEMBL14031156 | 0.86 | ADRB3 (0.46) | ADRB3ADRA2BADRA2CCTSBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7504378-B2 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-17 | — | — | US | disclosed |
| US-7504378-B2 | Macrocyclic peptides active against the hepatitis C virus | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-17 | — | — | US | disclosed |